CLOVER Collected Literature in Organized and Valuable Repository
Not a member yet
8005 research outputs found
Sort by
Housing Systems Affect Eggshell Lightness and Free Amino Acid Contents of Egg Albumen in Tosa-Jidori Chickens : A Preliminary Research
Get PDFjournal articleMany countries have gradually shifted to animal welfare-friendly housing systems for egg layers. However, there is still no consensus among researchers on whether the housing system affects egg quality traits. Therefore, this study aimed to determine the effects of housing systems on egg traits and free amino acid contents of albumen and yolk using two types of housing systems, the conventional cage (cage) system and a floor rearing (litter) system. Tosa-jidori (n = 20) hens were divided into two groups. Experiments during the 7 weeks were performed twice by switching the housing systems (first and second stages). One-way analysis of variance was used to evaluate the effects of housing systems on body weight gain, egg traits, albumen and yolk amino acid contents, and fecal corticosterone. We observed significant housing effects in body weight gain, eggshell weight, yolk weight, eggshell thickness, eggshell lightness, and several albumen amino acids (A_Gln, A_His, A_Met, A_Cys, A_Lys, A_Asp, A_Glu, A_Ser, A_Thr, A_Ala, A_Pro, and A_Phe). Notably, a robust effect was seen in eggshell lightness, even after switching housing systems. These results suggest that eggshell lightness and several egg traits, including albumen amino acid contents, can be changed by using the different housing systems.journal articl
Safety and efficacy of elapegademase in patients with adenosine deaminase deficiency : A multicenter, open-label, single-arm, phase 3, and postmarketing clinical study
Get PDFjournal article[Introduction] Adenosine deaminase (ADA) deficiency is an ultrarare inherited purine metabolism disorder characterized by severe combined immunodeficiency. Elapegademase-lvlr is a new pegylated recombinant bovine ADA used in enzyme-replacement therapy (ERT) for ADA deficiency. Therefore, replacement with the new drug may eliminate the infectious risks associated with the currently used bovine intestinal-derived product, pegademase. [Methods] We conducted a multicenter, single-arm, open-label, phase 3, and postmarketing clinical study of elapegademase for patients with ADA deficiency. The following biochemical markers were monitored to determine an appropriate dose of elapegademase: the trough deoxyadenosine nucleotide (dAXP) level ≤0.02 μmol/mL in erythrocytes or whole blood and the trough serum ADA activity ≥1100 U/L (equivalent to plasma levels ≥15 μmol/h/mL) indicated sufficient enzyme activity and detoxification as efficacy endpoints and monitored adverse events during the study as safety endpoints. [Results] A total of four patients (aged 0–25 years) were enrolled. One infant patient died of pneumonia caused by cytomegalovirus infection whereas the other three completed the study and have been observed in the study period over 3 years. The infant patient had received elapegademase at 0.4 mg/kg/week until decease and the others received elapegademase at maximum doses of 0.3 mg/kg/week for 164–169 weeks. As a result, all four patients achieved undetectable levels of dAXPs together with sufficient enzyme activity, increased T and B cell numbers, and slightly elevated and maintained IgM and IgA immunoglobulin levels. Serious adverse events occurred in three patients, all of which were assessed as unrelated to elapegademase. [Conclusions] This study showed that elapegademase had comparable safety and efficacy to pegademase as ERT for ADA deficiency by demonstrating stable maintenance of sufficient ADA activity and lowering dAXP to undetectable levels, while no drug-related adverse events were reported (Trial registration: JapicCTI-163204).journal articl
Phage therapy : Targeting intestinal bacterial microbiota for the treatment of liver diseases
Get PDFjournal articlePhage therapy has been overshadowed by antibiotics for decades. However, it is being revisited as a powerful approach against antimicrobial-resistant bacteria. As bacterial microbiota have been mechanistically linked to gastrointestinal and liver diseases, precise editing of the gut microbiota via the selective bactericidal action of phages has prompted renewed interest in phage therapy. In this review, we summarise the basic virological properties of phages and the latest findings on the composition of the intestinal phageome and the changes associated with liver diseases. We also review preclinical and clinical studies assessing phage therapy for the treatment of gastrointestinal and liver diseases, as well as future prospects and challenges.journal articl
Effect of live yeast Saccharomyces cerevisiae supplementation on immune factors in Japanese Black calves during the growth periods
Get PDFjournal articleThe aim of this study was to investigate changes in expression levels of immune factors of peripheral blood mononuclear cells (PBMC) after oral supplementation of live yeast Saccharomyces cerevisiae to healthy Japanese Black (JB) calves. This study examined JB calves (N=28): 14 calves (SC Group) received 10 g/calf/day of Saccharomyces cerevisiae (SC) (Acti-Saf Sc 47), and the other calves did not receive supplement (Control Group). Blood samples were collected 9 times during experimental period (1, 2, 3, 4, 5, 6, 7, 8 and 9 months of age), and analyzed for cytokines and chemokines mRNA expression of PBMC using Real-time PCR. The level of beta Hydroxybutanoic acid (BHB) in the SC Group was significantly high at 7 and 8 months of age compared to that in the Control Group. Lymphocyte counts in the SC Group were significantly higher at 2 and 5 to 6 months of age compared to the Control Group. Significant differences were found for IL-12p40 level at 4, 7 and 9 months of age, and for IFN-γ level at 6, 7 and 8 months of age. The level of CXCR3 was significantly higher at 6 to 7 months of age by dietary SC supplementation. These results indicated that SC supplementation improved the cellular immune responses of JB calves.journal articl
Decreased Immunoreactivity of Hepatitis E Virus Antigen Following Treatment with Sakhalin Spruce (Picea glehnii) Essential Oil
Get PDFjournal articleThe hepatitis E virus (HEV) causes a common infectious disease that infects pigs, wild boars, deer, and humans. In most cases, humans are infected by eating raw meat. Some essential oils have been reported to exhibit antiviral activities. In this study, in order to investigate the anti-HEV properties of essential oils, the immunoreactivities of HEV antigen proteins against the relevant antibodies were analyzed after the HEV antigens underwent treatment with various essential oils. The essential oils extracted from the tea tree, which was previously reported to exhibit antiviral activity, lavender, and lemon had strongly reduced activity. We found that treatment with the essential oil prepared from Sakhalin spruce was associated with the strongest reduction in immunoreactivity of HEV antigen protein(s) among the tested substances. The main volatile constituents of Sakhalin spruce essential oil were found to be bornyl acetate (32.30 %), α-pinene (16.66 %), camphene (11.14 %), camphor (5.52 %), β-phellandrene (9.09 %), borneol (4.77 %), and limonene (4.57 %). The anti-HEV properties of the various components of the essential oils were examined: treatment with bornyl acetate, the main component of Sakhalin spruce oil, α-pinene, the main component of tea tree oil, and limonene, the main component of lemon oil, resulted in a strong reduction in HEV antigen immunoreactivity. These results indicate that each main component of the essential oils plays an important role in the reduction of the immunoreactivity of HEV antigen protein(s); they also suggest that Sakhalin spruce essential oil exhibits anti-HEV activity. In a formulation with the potential to eliminate the infectivity of HEV in foodborne infections, this essential oil can be applied as an inactivating agent for meat processing and cooking utensils, such as knives and chopping boards.journal articl
Indoor temperature, humidity, and microorganisms in traditional and modern houses in Japan
Get PDFjournal articleMicroorganisms in our living environment may affect human health. Microbial suppression by air cleaners and disinfecting agents may provide protection from pathogenic materials. However, excessive microbial suppression can negatively affect human health; thus, an appropriate level of microbiome control is beneficial. It is not well understood how physical environmental conditions, such as temperature and relative humidity, and human lifestyles and behaviors affect indoor microorganisms. To understand the relationship between physical environmental conditions and microbial communities in the human living environment, we measured temperature and relative humidity and collected microbial samples in modern and traditional Japanese houses. In this study, bacteria and fungi were the target microorganisms. In both houses, the DNA concentration of microorganisms on floor surfaces was high when the average relative humidity of the room was high. The same tendency was observed for the beam and pillar surfaces in the traditional house. Although more careful consideration is needed for some indoor surfaces, such as storage ceilings and air conditioner outlets, seasonal changes in relative humidity and DNA concentrations of microorganisms on indoor surfaces exhibit some correlation.journal articl